| 1 | [SID48415578] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 48415578 | | CID | 232 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 2 | [SID85209622] | Active | | | Ligands of Class C GPCRs [AID2059, Type: other] | | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85209622 | | CID | 232 | | Outcome | Active | | BioAssay | Ligands of Class C GPCRs | | AID | 2059 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 3 | [SID125470] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 125470 | | CID | 232 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 4 | [SID124879204] | Inactive | Potency | | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table | |
|
| 5 | [SID124879204] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table | |
|
| 6 | [SID124879204] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table | |
|
| 7 | [SID124879204] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table | |
|
| 8 | [SID124879204] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table | |
|
| 9 | [SID124879204] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124879204 | | CID | 232 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table | |
|
| 10 | [SID565762] | Inactive | | | NCI AIDS Antiviral Assay [AID179, Type: confirmatory] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 565762 | | CID | 232 | | Outcome | Inactive | | BioAssay | NCI AIDS Antiviral Assay | | AID | 179 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 11 | [SID565762] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 565762 | | CID | 232 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
